Viewing Study NCT05896761


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2025-12-25 @ 12:56 PM
Study NCT ID: NCT05896761
Status: COMPLETED
Last Update Posted: 2023-09-18
First Post: 2023-05-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants
Sponsor: ViiV Healthcare
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 207966-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View